Search tips
Search criteria 


Logo of jexpmedHomeThe Rockefeller University PressEditorsContactInstructions for AuthorsThis issue
J Exp Med. 1990 October 1; 172(4): 1011–1017.
PMCID: PMC2188593

Molecular basis of polymorphisms of human complement component C3


C3 exhibits two common allotypic variants that may be separated by gel electrophoresis and are called C3 fast (C3 F) and C3 slow (C3 S). C3 F, the less common variant, occurs at appreciable frequencies only in Caucasoid populations (gene frequency = 0.20). An increased prevalence of the C3 F allele has been reported in patients with partial lipodystrophy, IgA nephropathy, and Indian childhood hepatic cirrhosis. Studies of the genomic organization of the human C3 gene led to the identification of a single change (C to G) between C3 S and C3 F at nucleotide 364 in exon 3. This leads, at the translation level, to the substitution of an arginine residue (positively charged) in C3 S for a glycine residue (neutral) in C3 F. This substitution results in a polymorphic restriction site for the enzyme HhaI. The resulting restriction fragment length polymorphism (RFLP) was investigated using genomic DNA, amplified using the polymerase chain reaction; there was absolute concordance between the genomic polymorphism and the distribution of C3 S and C3 F in 50 normal subjects. The molecular basis of a second structural polymorphism, defined by the monoclonal antibody HAV 4-1, was also characterized. The polymorphic determinant was identified at codon 314 in the exon 9 of the beta chain where a leucine residue (HAV 4-1+) is substituted for a proline residue (HAV 4- 1-). Identification of the amino acid sequences of these polymorphic variants will facilitate characterization of possible functional differences between different allotypes of C3. Three RFLPs (BamHI, EcoRI, and SstI) were located to introns in the C3 gene. There was no allelic association between these three RFLPs, or between the RFLPs and the C3 F/S polymorphic site. Genetic equilibration of these polymorphisms has occurred within a gene of 41 kb.

Full Text

The Full Text of this article is available as a PDF (749K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Wieme RJ, Demeulenaere L. Genetically determined electrophoretic variant of the human complement component C'3. Nature. 1967 Jun 3;214(5092):1042–1043. [PubMed]
  • Alper CA, Propp RP. Genetic polymorphism of the third component of human complement (C'3). J Clin Invest. 1968 Sep;47(9):2181–2191. [PMC free article] [PubMed]
  • Tongmao Z. Genetic polymorphisms of C3 and Bf in the Chinese population. Hum Hered. 1983;33(1):36–38. [PubMed]
  • Nishimukai H, Kitamura H, Sano Y, Tamaki Y. C3 variants in Japanese. Hum Hered. 1985;35(2):69–72. [PubMed]
  • Rittner C, Rittner B. Report 1973-1974 of the Reference Laboratory for the polymorphism of the third component (C3) of the human complement system. Vox Sang. 1974;27(5):464–472. [PubMed]
  • Koch C, Behrendt N. A novel polymorphism of human complement component C3 detected by means of a monoclonal antibody. Immunogenetics. 1986;23(5):322–325. [PubMed]
  • Davies KE, Jackson J, Williamson R, Harper PS, Ball S, Sarfarazi M, Meredith L, Fey G. Linkage analysis of myotonic dystrophy and sequences on chromosome 19 using a cloned complement 3 gene probe. J Med Genet. 1983 Aug;20(4):259–263. [PMC free article] [PubMed]
  • Dandieu S, Lucotte G. Restriction fragment length polymorphism of the human C3 complement gene. Exp Clin Immunogenet. 1986;3(1):34–37. [PubMed]
  • Donald JA, Ball SP. Approximate linkage equilibrium between two polymorphic sites within the gene for human complement component 3. Ann Hum Genet. 1984 Jul;48(Pt 3):269–273. [PubMed]
  • Arvilommi H. Capacity of complement c3 phenotypes to bind on to mononuclear cells in man. Nature. 1974 Oct 25;251(5477):740–741. [PubMed]
  • Kay PH, Natsuume-Sakai S, Hayakawa J, Dawkins RL. Different allotypes of C3 degrade at different rates. Immunogenetics. 1985;22(6):563–569. [PubMed]
  • Srivastava N, Srivastava LM. Association between C3 complement types and Indian childhood cirrhosis. Hum Hered. 1985;35(4):268–270. [PubMed]
  • Rambausek M, van den Wall Bake AW, Schumacher-Ach R, Spitzenberg R, Rother U, van Es LA, Ritz E. Genetic polymorphism of C3 and Bf in IgA nephropathy. Nephrol Dial Transplant. 1987;2(4):208–211. [PubMed]
  • Sissons JG, West RJ, Fallows J, Williams DG, Boucher BJ, Amos N, Peters DK. The complement abnormalities of lipodystrophy. N Engl J Med. 1976 Feb 26;294(9):461–465. [PubMed]
  • de Bruijn MH, Fey GH. Human complement component C3: cDNA coding sequence and derived primary structure. Proc Natl Acad Sci U S A. 1985 Feb;82(3):708–712. [PubMed]
  • Fong KY, Botto M, Walport MJ, So AK. Genomic organization of human complement component C3. Genomics. 1990 Aug;7(4):579–586. [PubMed]
  • Koch C, Skjødt K, Laursen I. A simple immunoblotting method after separation of proteins in agarose gel. J Immunol Methods. 1985 Nov 28;84(1-2):271–278. [PubMed]
  • Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975 Nov 5;98(3):503–517. [PubMed]
  • Feinberg AP, Vogelstein B. "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum. Anal Biochem. 1984 Feb;137(1):266–267. [PubMed]
  • Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. [PubMed]
  • Behrendt N, Hansen OC, Ploug M, Barkholt V, Koch C. Localization and functional significance of a polymorphic determinant in the third component of human complement. Mol Immunol. 1987 Oct;24(10):1097–1103. [PubMed]
  • Botto M, Fong KY, So AK. EcoRI polymorphism in the human third complement component (C3) gene. Nucleic Acids Res. 1990 May 11;18(9):2833–2833. [PMC free article] [PubMed]
  • Behrendt N. Human complement component C3: characterization of active C3 S and C3 F, the two common genetic variants. Mol Immunol. 1985 Aug;22(8):1005–1008. [PubMed]
  • Antonarakis SE, Boehm CD, Giardina PJ, Kazazian HH., Jr Nonrandom association of polymorphic restriction sites in the beta-globin gene cluster. Proc Natl Acad Sci U S A. 1982 Jan;79(1):137–141. [PubMed]
  • Chakraborty R, Lidsky AS, Daiger SP, Güttler F, Sullivan S, Dilella AG, Woo SL. Polymorphic DNA haplotypes at the human phenylalanine hydroxylase locus and their relationship with phenylketonuria. Hum Genet. 1987 May;76(1):40–46. [PubMed]
  • Lambris JD. The multifunctional role of C3, the third component of complement. Immunol Today. 1988 Dec;9(12):387–393. [PubMed]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press